arrow
H

Hideharu Kimura

Kanazawa University Hospital
H指数:29
被引数:3,502

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Plain language summary of the J-TAIL-2 study results: a study of Japanese patients with extensive-stage small cell lung cancer that followed their treatment with atezolizumab plus chemotherapy over time

J-TAIL-2研究结果的简明摘要:一项关于日本广泛期小细胞肺癌患者接受阿替利珠单抗联合化疗长期随访的研究

2026-10-010
OA
Prognostic value of preoperative ctDNA and pathological venous invasion for recurrence in EGFR-mutated non-small cell lung cancer

EGFR突变非小细胞肺癌中术前ctDNA和病理静脉侵犯对复发的预测价值

2025-11-040
PRE
EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer
2024-11-010
OAAI
A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study

不适合III期放化疗的非小细胞肺癌患者放疗后durvalumab治疗的2期试验: spiri-rt研究

2023-12-013
OA
Clinical impact of amrubicin monotherapy in patients with relapsed small cell lung cancer: a multicenter retrospective study
2022-09-011
OAAI
Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings

在现实环境中使用免疫检查点抑制剂单药治疗的非小细胞肺癌患者的长期生存

2022-09-0115
PRE
A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR-Mutant NSCLC

EGFR突变型NSCLC患者奥希替尼治疗后基于免疫检查点抑制剂的治疗的真实世界分析

2022-09-018
OA
Suitability of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration versus Paired Transbronchial Biopsy Specimens for Evaluating Programmed Death Ligand-1 Expression in Stage III and IV Lung Cancer: A Comparative Retrospective Study
2021-01-010
OAAI